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Abstract
AIM—To determine if transient neurological abnormalities (TNA) at 9 months corrected age 
predict cognitive, behavioral, and motor outcomes at 6 years of age in extremely preterm infants.
METHOD—A cohort of 124 extremely preterm infants (mean gestational age 25.5wk; 55 males, 
69 females), admitted to our unit between 2001 and 2003, were classified based on the Amiel-
Tison Neurological Assessment at 9 months and 20 months corrected age as having TNA (n=17), 
normal neurological assessment (n=89), or neurologically abnormal assessment (n=18). The 
children were assessed at a mean age of 5 years 11 months (SD 4mo) on cognition, academic 
achievement, motor ability, and behavior.
RESULTS—Compared with children with a normal neurological assessment, children with TNA 
had higher postnatal exposure to steroids (35% vs 9%) and lower adjusted mean scores on spatial 
relations (84 [standard error {SE} 5] vs 98 [SE 2]), visual matching (79 [SE 5] vs 91 [SE 2]), 
letter–word identification (97 [SE 4] vs 108 [SE 1]), and spelling (76 [SE 4] vs 96 [SE 2]) (all 
p<0.05).
INTERPRETATION—Despite a normalized neurological assessment, extremely preterm 
children with a history TNA are at higher risk for lower cognitive and academic skills than those 
with normal neurological findings during their first year of school.
Extremely preterm infants, defined as those born before 28 weeks gestational age, are at an 
elevated risk both for developmental delays and for neurological injury. Although the 
survival of extremely preterm infants without substantial neurosensory impairment has 
increased, the burden of cognitive, learning, and behavior problems still affects more than 
50% of this population.1,2 Unfortunately, developmental assessments in early childhood 
generally have poor validity in predicting which children are most likely to exhibit these 
problems at school age.3 With the tightening of governmental budgets, it is important to 
direct resources to those most likely to benefit. Further research is needed on early 
childhood characteristics associated with school-age outcomes, so that the children in 
greatest need can receive more focused interventions before school entry.
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For some extremely preterm infants, signs of cerebral palsy (CP) will appear during the first 
year of their life with abnormal muscle tone and/or delayed motor milestones. There is also 
an inadequately studied subgroup of preterm infants who exhibit similar tone abnormalities 
suggestive of developing CP during infancy, but this subgroup appears to outgrow these 
impairments. This subgroup exhibits a syndrome that has previously been referred to as 
transient neurological abnormalities (TNA).4 TNA affects an estimated 11% to 60% of very 
low birthweight infants and an unknown number of term and larger preterm infants.5,6 The 
first to recognize this pattern of transient abnormal neurological signs was Drillien in 1972.5 
She described a syndrome of abnormalities in muscle tone, posture, and primitive reflexes 
which resolved by 12 months corrected age. After following a cohort of very low 
birthweight infants until 6 to 7 years of age, Drillien et al.7 found that those children with 
TNA in infancy went on to have normal IQ but increased learning difficulties. Subsequent 
studies on TNA assessing long-term developmental and behavioral outcomes have had 
conflicting results. While some studies have found no association of TNA with later 
outcomes,8–10 others report increased difficulties with language, motor skills, and 
hyperactivity.11–13 Interpretation of these studies is difficult because they often included 
heterogeneous cohorts of preterm and term infants born before the 1990s. These studies’ 
results may not reflect the outcomes for extremely preterm newborn infants managed with 
current neonatology practice.
The primary aim of this study was to determine if the presence of TNA in extremely preterm 
infants during their first year of life predicts an increased risk of cognitive, behavioral, and 
motor problems at age 6 years. We hypothesized an increased risk of a broad spectrum of 
difficulties in these three domains at school entry. Our secondary aim was to determine the 
perinatal predictors of TNA for preterm children born since the year 2000.
METHOD
Study population
This was a prospective cohort study of 224 extremely preterm infants (<28wk gestation) 
admitted to the neonatal intensive care unit of Rainbow Babies & Children’s Hospital in 
Cleveland, Ohio, USA, between 1 January 2001 and 31 December 2003. Forty-four infants 
(20%) died before discharge and eight children with major malformations were excluded. Of 
the remaining 172 infants, 133 were recruited (77%). Of these 133 infants, 124 (93%) had 
complete neurological assessments in early childhood to allow for neurological 
classification (Fig. 1).
Neonatal and maternal data were collected as part of our neonatal follow-up program at the 
time of infant discharge. As part of routine high-risk follow-up at 9 and 20 months corrected 
age, infants underwent a neurological examination based on the Amiel-Tison Neurological 
Assessment14 and completed the Bayley Scales of Infant Development (2nd edition) 
(BSID-2).15 The Amiel-Tison assessment evaluates active and passive muscle tone based on 
age-specific norms that change as the myelination progresses and the balance between the 
corticospinal and subcortical systems shifts. Children were classified at each visit as either 
having a normal or abnormal neurological assessment based on their muscle tone. Children 
who had a normal tone at both 9 and 20 months (n=89) were classified for this study as 
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having a neurologically normal assessment (NNA). Children were classified as having TNA 
(n=17) if the assessment was abnormal at 9 months and then was followed by a normal 
assessment at 20 months. Children with an abnormal assessment (CP, hypotonia, or 
hypertonia) at 20 months (n=18) were classified as abnormal regardless of the outcome of 
the 9 month assessment. Scores from the BSID-2 included both the Mental Development 
Index (MDI) and the Psychomotor Developmental Index (PDI). Comparison of participants 
and non-participants based on demographic factors, neurological risk factors, and maternal 
social risk factors showed no statistically significant differences except for a higher 
recruitment among black survivors. Black participants were 61% (76/124) of the study 
sample but only 55% (95/172) of the surviving cohort (p=0.01).
Data collection
This is a secondary analysis of a subset of patients followed as part of a larger study of 
school-age outcomes in extremely low birthweight infants. Families were recruited for the 
school-age follow-up before their first year of kindergarten (the first year of formal 
education within the USA, at 5 to 6 years of age). During their first year of kindergarten, 
children were tested on areas of cognition, academic achievement, and motor function 
during a half-day session. Families completed questionnaires on the child’s health, family 
demographics, and behavior. Cognitive skills were assessed through an age-standardized 
brief intelligence assessment from the Woodcock–Johnson Tests of Cognitive Abilities (3rd 
edition).16 School achievement was assessed with select subtests of the Woodcock–Johnson 
Tests of Achievement (3rd edition), including letter word identification, spelling, and 
applied math problems.17 Achievement test results were standardized based on duration of 
time in school. Motor ability was assessed with the Bruininks–Oseretsky Test of Motor 
Proficiency (2nd edition),18 and visual–motor ability with the Beery Developmental Test of 
Visual-Motor Integration (5th edition).19 Parent ratings of behavior problems were obtained 
using the Child Behavior Checklist,20 specifically T scores from the externalizing, 
internalizing, attention, and total behavior problem scales. Socio-economic status was 
defined as the mean of the sample z-scores for maternal education, caregiver occupation,21 
and US census-based median family income.22 The University Hospitals Case Medical 
Center institutional review board reviewed and approved this study. Informed consent was 
obtained from parents and teachers.
Statistical analysis
Group comparisons of clinical and demographic characteristics were completed using the 
analysis of variance for continuous variables, Kruskal–Wallis tests for severely skewed 
continuous variables followed by Kruskal–Wallis pairwise comparison follow-up tests for 
exact p values, and the χ2 or Fisher’s exact test for categorical variables. Owing to the non-
parametric distribution of the BSID-2 scores, median scores were calculated and Hodges–
Lehman median differences were estimated. Kindergarten testing scores were compared 
between the three groups using analysis of covariance with included covariates of ethnicity, 
sex, and socio-economic status. Relative risk for low IQ was adjusted for covariates and 
calculated by Poisson regression. To include the full cohort of children for cognitive and 
academic testing, those who were too low functioning cognitively to complete testing were 
assigned the lowest possible score of 50 for the BSID-2 and 40 for the Woodcock–Johnson 
Harmon et al. Page 3
Dev Med Child Neurol. Author manuscript; available in PMC 2016 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
tests, which is 4SD below the standardized mean score. Statistical testing was conducted 
using two-sided alternatives with a type I error level of 0.05.
RESULTS
Group characteristics
The TNA group and the NNA group did not differ significantly in gestational age, 
birthweight, sex, or perinatal morbidities including infection, necrotizing enterocolitis, 
patent ductus arteriosus, bronchopulmonary dysplasia, and abnormal cerebral ultrasound 
findings (Table I). However, the TNA group, compared with the NNA group, had a higher 
proportion of children who were white, had married mothers, and who received postnatal 
steroid therapy. Compared with the group with persistent neurological abnormalities, the 
TNA group had a lower proportion of severely abnormal head ultrasounds, defined as grade 
III to IV intraventricular hemorrhage and/or periventricular leukomalacia (p=0.014).
Early childhood assessments
Based on the Amiel-Tison assessment, the presence of hypotonia at the 9-month assessment 
was more likely to be associated with a normal assessment at 20 months of age compared 
with any form of hypertonia (suspected CP, hypertonia, or mixed hypertonia/hypotonia) 
(relative risk=3.9, 95% confidence interval [CI] 1.6–9.5, p=0.001) (Tables II and III). At 9 
months corrected age, the children with TNA had significantly lower scores on both the 
MDI and PDI of the BSID-2 compared with the NNA group. At 20 months corrected age 
compared with the NNA group, the TNA group continued to have a significantly lower PDI, 
whereas the groups did not differ significantly on the MDI. Comparison of the TNA group 
and the persistently abnormal neurological assessment group at 9 months showed higher 
MDI scores for the TNA group but similar PDI scores, whereas at 20 months corrected age 
the groups had similar MDI and PDI scores.
Kindergarten outcomes
The children in all three groups were approximately 6 years of age at the time of evaluation 
and did not differ significantly in preschool attendance (Table IV). Children with TNA had 
higher rates of participation in a special-needs school classroom than the NNA group but did 
not differ on overall rates of individualized educational programs. Most children (83%) with 
persistent neurological abnormities had an individualized educational program and 44% 
required a special-needs classroom setting.
All three groups of extremely preterm infants scored below age standards on many portions 
of the cognitive, motor, and achievement tests. Group comparisons revealed a consistent 
pattern of cognitive outcomes in which the TNA group scored better than the persistent 
neurological abnormality group but more poorly than the NNA group. The TNA group 
scored significantly higher than the persistent neurological abnormality group on all 
cognitive and motor tests except those assessing verbal comprehension, spatial relations, and 
mathematics, but scored lower than the NNA group on measures of spatial relations, visual 
matching, reading, and spelling. There was a trend with borderline significance (p=0.065) of 
lower motor scores in the TNA group compared with the NNA group. There was also a 
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suggestion of lower mean IQ in the TNA group compared with the NNA group (p=0.059). 
More children in the TNA group had an adjusted IQ<70 compared with the NNA group 
(relative risk=3.8, CI 95% 1.6–9.1, p=0.002) but the risk did not vary significantly between 
the TNA group and the group with persistent neurological abnormalities (relative risk=0.8, 
95% CI 0.3–1.7, p=0.5). The groups did not differ significantly on the internalizing, 
externalizing, or total behavior problem scales of the Child Behavior Checklist, with mean 
scores for all three groups falling well within normative standards.
DISCUSSION
Extremely preterm newborn infants with TNA in infancy continued to show deficits in 
multiple developmental domains at school age compared with those without neurological 
abnormalities. This is the first study, to our knowledge, that examines TNA in a preterm 
cohort born since the routine introduction of antenatal steroids and surfactant. This is also 
the first study of school-age outcomes of children with TNA that includes a comparison 
group with persistent neurological abnormalities. The inclusion of this comparison group 
places these results in the context of the full spectrum of neurological outcomes of 
extremely preterm children. The BSID-2 showed significant motor and cognitive delays for 
both the TNA and the persistent neurological abnormalities groups. The average MDI scores 
at 20 months for all three groups were greater than 1SD below the normative mean, as is 
consistent with BSID-2 scores reported in the USA for the extremely preterm population and 
confirming the severe early delays observed in children born extremely preterm.23 At 6 
years of age, the mean scores for children with TNA in cognitive and motor testing fell 1–
2SD below standards for age. By comparison, the children in the NNA group had mean 
scores on cognitive and motor tests that were all within 1SD of normative standards. The 
TNA group also scored significantly below the NNA group in reading and spelling skills. 
Children with persistent neurological abnormalities scored consistently 2–3SD below the 
standard on cognitive and motor testing. This study failed to reveal group differences in 
parent ratings of child behavior problems.
Previous research on the school-age outcomes of TNA has been less conclusive, with some 
studies reporting continued developmental delays at school age but others failing to find 
lasting effects.7–13 This may be partly explained by the age the neurological deficits were 
detected and the length of time until resolution of these neurological deficits. The peak 
prevalence of TNA is 4 to 7 months.6,8,24 There are some hints that the longer the 
neurological deficit continues before resolving, the greater risk for longer-term 
developmental consequences. In a study of preterm infants born in 1978, scores on cognitive 
testing were lower at 3 and 5 years if TNA lasted greater than 6 months.25 Hack also 
reported in an abstract that mean IQ at 31 months in a group of very low birthweight infants 
with TNA born in 1977 was lower for children whose assessments normalized between 8 
and 31 months than for those with a normal assessment before 8 months (Maureen Hack, 
personal communication). The identification in our study of TNA at 9 months corrected age 
may have reduced the number of children with TNA but it allowed us to exclude less 
severely affected children. In comparison, several previous studies of preterm infants 
identified with TNA at 4 to 7 months of age have failed to reveal residual effects at school 
age.8,9,26 Another possible reason for the discrepancy between our results and previous 
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long-term follow-up studies is our extremely preterm population. The children from this 
cohort were born at a much earlier stage in neurological development than those in most of 
the previous studies. Risks for school-age sequelae may also have been increased by our use 
of a gestational-age-based cohort rather than a weight-based cohort. Our cohort excluded 
higher gestational age infants born small for gestational age who may have a different 
neurological risk pattern.
The infants with TNA were similar in demographic and perinatal morbidities to the NNA 
group, with no significant differences in several neonatal factors previously associated with 
increased risk of motor problems, including absence of maternal antenatal steroids,27 
chorioaminitis,28 infection/necrotizing enterocolitis,29 and severely abnormal head 
ultrasound.30 The most notable difference between the groups was the increased postnatal 
steroid exposure in the children with TNA compared with the neurological normal group. 
The use of postnatal steroids has been a well-established risk factor for CP and 
developmental delay since the early 2000s31 but has not, to our knowledge, been associated 
with TNA. We did not replicate results of previous studies demonstrating associations of 
TNA with mechanical ventilation6,9, low Apgar scores,6,8 gestational age,32 and 
birthweight.9,32 These disparities may reflect sample differences or improved delivery-room 
management. The higher rates of TNA in married versus unmarried caregivers and in 
children of white versus black ethnicity were unexpected. Speculation about possible 
reasons for these associations may thus be unwarranted pending replication of the findings 
in other samples.
The etiology of TNA is unclear. Maturational delay or dysfunction of myelination has been 
suggested by one previous study that evaluated brainstem auditory evoked potentials in 
preterm children with TNA at 2 and 5 months.33 This is consistent with the well-established 
association between white matter damage detected at term-corrected age with cognitive and 
motor impairment at school age in preterm children.34,35 Residual cognitive impairment in 
the TNA group, despite resolution of early neuromotor deficits, may reflect limitations of 
compensatory neural plasticity.36 In our study, hypotonia was more frequently transient than 
hypertonia. Delayed myelination37 and cerebellar injury38 have both been associated with 
hypotonia and could either alone or together explain the high level of residual cognitive 
issues, especially the visual spatial difficulties and language problems.37,38 Hypertonia may 
represent more profound dysmyelination or a different mechanism of injury.
There are many limitations to our study. These include the relatively small number of 
children in the TNA and persistent neurological abnormalities groups, and the 
preponderance of white infants in the TNA group. Group sizes were sufficient to 
demonstrate residual effects of both forms of early neurological abnormality on cognition 
and motor performance, and ethnicity was controlled in the analysis. However, replication 
with a larger sample size would be useful, particularly in characterizing children with TNA 
and their outcomes. Another limitation is that our sample comprised only 74% of the 
survivors of extremely preterm birth. With the exception of ethnicity, the participants did not 
differ significantly from non-participants from our larger birth cohort in sociodemographic 
or perinatal factors, suggesting that our sample was largely representative of our total 
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population. Our cohort also may not be representative of children born in other regions of 
the USA or outside academic medical centers.
By definition, children with TNA do not have neurological abnormalities after 1 to 2 years 
of age and thus may not be identified for special services before school entry. Unfortunately, 
once children’s motor assessments normalize they may no longer qualify for therapy 
services and families may be falsely reassured that their child is no longer at an increased 
risk for developmental issues. All preterm infants are at risk of having undiagnosed 
developmental problems but the children with TNA appear to be at greater risk. Future 
research should focus on developing effective interventions to target this population before 
school entry and to assess longitudinally whether the deficits of the children with TNA will 
become more evident as schoolwork becomes more challenging or if they will catch up to 
peers with advancing age.
In conclusion, extremely preterm children with TNA continue to have cognitive deficits at 
school entry relative to those without histories of abnormality on neurological examination 
in infancy. Despite a normalized neurological examination, children with TNA represent a 
high-risk group deserving early childhood surveillance. As children with TNA transition to 
school, they may also require additional developmental testing to ensure their educational 
needs are met and to increase their chance of school success.
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ABBREVIATIONS
BSID-2 Bayley Scales of Infant Development (2nd edition)
MDI Mental Development Index
NNA Neurologically normal assessment
PDI Psychomotor Developmental Index
TNA Transient neurological abnormalities
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What this paper adds
• Extremely preterm infants with transient neurological abnormalities in infancy 
are at greater risk of cognitive problems at 6 years.
• Hypotonia in infancy is more likely to be transient than hypertonia in extremely 
preterm infants.
• Postnatal steroid exposure increases the risk of developing transient 
neurological abnormalities.
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Figure 1. 
Flow chart of participants.
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Table II
Infant and toddler neurological assessment
Transient
neurological
abnormalities (n=17)
Persistent
neurological
abnormalities (n=18)
Neurological assessment resultsa 9mo 20mo 9mo 20mo
Hypertonia, n 2 0 5 3
Hypotonia, n 13 0 3 3
Hypertonia and hypotonia, n 1 0 2 0
Cerebral palsy, n 1 0 6 12
Normal assessment, n 0 17 2 0
a
Results are based on the Amiel-Tison assessment.
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